此页面上的某些内容不提供英文版本,默认显示为当前可用的语言。

DREADD agonist 21 dihydrochloride

目录号 数量 价格 提前通知时间
3607-1mg 1 mg –   现货
3607-5mg 5 mg $109 现货
3607-10mg 10 mg $159 现货
Found better price? Let us know and we will propose the way forward!

DREADD agonist 21 (Compound 21, C21) is a synthetic compound for selective activation of hM3Dq (excitatory) and hM4Di (inhibitory) DREADDs (Designer Receptor Exclusively Activated by Designer Drugs) derived from the human muscarinic acetylcholine M3 (hM3) receptor. It does not agonize the hM3 receptor and displays weaker binding affinities for histamine H1, serotonin 5-HT2A, 5-HT2C, and α1A-adrenergic receptors (Ki = 6, 66, 170, and 280 nM, respectively) [1].

DREADD agonist 21 is routinely used as a chemogenetic tool for remotely controlling neuronal activity. It displays excellent brain permeability and capability to activate neurons expressing hM3Dq DREADDs and inhibit activity in neurons expressing hM4Di DREADDs in vivo [2].

This product is dihydrochloride salt, a water-soluble version of DREADD agonist 21.

[1] Chen X. et al. The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs. ACS Chem. Neurosci. 2015. 6(3). 476-484.

[2] Thompson K.J. et al. DREADD agonist 21 is an effective agonist for muscarinic-based DREADDs in vitro and in vivo. ACS Pharmacol. Transl. Sci. 2018. 1(1). 61-72.

General properties

Appearance: yellow-brown powder
Molecular weight: 351.28
CAS number: 2250025-92-2
Molecular formula: C17H18N4
IUPAC name: 11-(1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine dihydrochloride
Solubility: in water, DMSO
Quality control: NMR 1H and HPLC-MS (95+%)
Storage conditions: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Desiccate.
安全数据表(MSDS): 下载
产品规格
您的商品已添加. 查看您的 购物车 或者 继续结账
商品数量不正确.